ARS Pharmaceuticals, Inc. (SPRY) closed the last trading session at $14.52, gaining 9.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $25.67 indicates a 76.8% upside potential. The average comprises three short-term price targets ranging from a low of $22 to a high of $30, with a standard deviation of $4.04. While the lowest estimate indicates an increase of 51.5% from the curre ...